LENZ Therapeutics (LENZ) Net Income (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Net Income data on file, last reported at -$41.5 million in Q1 2026.

• Net Income for Q1 2026 came in at -$41.5 million, down 184.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$109.0 million (down 128.37% YoY), and the FY2025 annual result was -$82.1 million, down 65.02% from the prior year.
• Net Income fell to -$41.5 million in Q1 2026 per LENZ's latest filing, from -$35.9 million in the prior quarter.
• Over five years, Net Income peaked at -$10.2 million in Q3 2024 and troughed at -$41.5 million in Q1 2026.
• A 5-year average of -$20.5 million and a median of -$16.7 million in 2025 frame the typical range for Net Income.
• The sharpest annual moves came in 2023 and 2026: Net Income surged 51.4% in 2023, then slumped 184.03% in 2026.
• A 5-year view of Net Income shows it stood at -$26.8 million in 2022, then increased by 9.77% to -$24.1 million in 2023, then jumped by 47.58% to -$12.7 million in 2024, then sank by 183.72% to -$35.9 million in 2025, then dropped by 15.59% to -$41.5 million in 2026.
• Business Quant data shows LENZ's Net Income at -$41.5 million in Q1 2026, -$35.9 million in Q4 2025, and -$16.7 million in Q3 2025.